Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Client Area Book a 7-day Readout
ICB International logo — Pioneering breakthrough technology enabling new non-invasive...

ICB International

Pioneering breakthrough technology enabling new non-invasive diagnostics and therapeutics for CNS diseases like neurodegeneration, cancer, and infections.

Founded 2008 Venture round Total: $895.00K Biotechnology, Health Care +1

General Information

Company Name ICB International
Founded Year 2008
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with ICB International. To contact ICB International, visit icbii.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ICB International compare?

A PDF of ICB International and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ICB International soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ICB International

ICB International is a biotechnology and healthcare startup that has been pioneering breakthrough technology in the field of non-invasive diagnostics and therapeutics for CNS diseases. Established in 2008, the company's unique blood-brain barrier permeable technology is at the forefront of addressing challenges associated with central nervous system diseases. Utilizing this platform technology, ICBI is working on developing FDA-approved non-invasive diagnostics and treatments for neurodegenerative, cancer, and infectious diseases. The company secured a $895.00K Venture Round investment on 19 April 2013, showcasing investor interest in their innovative approach. With a focus on cutting-edge solutions in the areas of neurodegeneration, cancer, and infections, ICB International stands as a promising player in the biotech and healthcare industry.

Business keywords: non-invasive diagnostics, therapeutics, CNS diseases, neurodegeneration, cancer treatment, infectious diseases, blood-brain barrier technology, immunology, biomedicine, FDA approval, central nervous system, platform technology, proprietary technology, California Biosciences International

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $895.00K -
19 Apr 2013

ICB International Alternatives & Competitors

View All Alternatives
ICB International vs
CNine Biosolutions
CNine Biosolutions

Advancing diagnostic precision through the uncharted potential of the complement system in infectiou...

Seed
2-10 employees
Biotechnology, Health Care
ICB International vs
Aliada Therapeutics
Aliada Therapeutics United States

Beyond boundaries: Crossing the blood-brain barrier to create the next generation of central nervous...

Venture round
26 employees
Biotechnology, Health Care
Compare ICB International vs Aliada Therapeutics
ICB International vs
Adaptive Biotechnologies Corp.
Adaptive Biotechnologies Corp. United States

Every immune system has a story to tell; the key is knowing how to listen.

IPO
654 employees
Biotechnology, Health Care
View all alternatives

FAQ About ICB International

Pioneering breakthrough technology enabling new non-invasive diagnostics and therapeutics for CNS diseases like neurodegeneration, cancer, and infections.
ICB International was founded in 2008.
ICB International operates in Biotechnology, Health Care and Health and Wellness. Its work centres on non-invasive diagnostics, therapeutics, CNS diseases and neurodegeneration.
ICB International has completed 1 funding round, raising a total of $895.00K. The latest funding stage is Venture round.
Top alternatives and competitors to ICB International include CNine Biosolutions, Aliada Therapeutics, Adaptive Biotechnologies Corp., AGY Therapeutics, Immunicon. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ICB International and CNine Biosolutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ICB International, https://bouncewatch.com/company/icb-international, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout